Diabetes News: Medicare Price Cuts for Diabetes, Other Drugs

Community (This content is not subject to review by Daily Kos staff prior to publication.)

Wednesday December 03, 2025 · 9:00 AM PST

2025/12/03 · 09:00

Medicare has just added another 15 drugs to the Medicare Maximum Fair Prices (MFPs) for prices that will take effect on January 1, 2027. The negotiations for these price cuts began under President Joe Biden, who is still looking out for us all in ways that the temporary R majorities and the broligarchy have not dared to take on. This program is set to continue at 15 drugs per year until we have deals on all of the drugs that Medicare was previously not allowed to negotiate over.

I make no promises about what the [redacted, but you know what I mean] will try in January, when the next group of 15 is due to be selected. Neither does he/it. He doesn’t yet know what he wants to do then.

🎩 2thanks
Full List of Drug Prices Being Cut by Medicare

Finding this list was not easy for me, but it’s easier for you:

According to the CMS, the 15 drugs included in this second round and their negotiated 30-day supply prices, compared to 2024 list prices, are:

Ozempic, Rybelsus, Wegovy (Type 2 diabetes/weight loss): $274 (was $959; Wegovy higher dose: $385)

Trelegy Ellipta (asthma): $175 (was $654)

Xtandi (prostate cancer): $7,004 (was $13,480)

Pomalyst (chemotherapy): $8,650 (was $21,744)

Ofev (idiopathic pulmonary fibrosis): $6,350 (was $12,622)

Ibrance (breast cancer): $7,871 (was $15,741)

Linzess (chronic constipation): $136 (was $539)

Calquence (cancer): $8,600 (was $14,228)

Austedo & Austedo XR (Huntington’s disease): $4,093 (was $6,623)

Breo Ellipta (COPD): $67 (was $397)

Xifaxan (IBS/diarrhea): $1,000 (was $2,696)

Vraylar (antipsychotic): $770 (was $1,376)

Tradjenta (diabetes): $78 (was $488)

Janumet & Janumet XR (diabetes): $80 (was $526)

Otezla (psoriatic arthritis): $1,650 (was $4,722)

Thanks, Joe! 💙

Three diabetes drugs highlighted.

Newer
Older

RSS